蛛网膜下腔出血后低钠血症发生率及其与结局的关联:系统评价与Meta分析
该系统评价与Meta分析纳入52项研究共10512例动脉瘤性蛛网膜下腔出血患者,低钠血症(血钠<135 mmol/L)合并发生率为37.0%(95%CI 31.7%-42.4%),低钠血症增加血管痉挛风险(OR 2.93,95%CI 1.77-4.84)并延长住院时间(16.4天 vs 8.0天,均差8.5天,95%CI 4.6-12.4),但与不良结局(GOS≤3)无显著关联(OR 1.15,95%CI 0.44-3.02)。
要点
- 动脉瘤性蛛网膜下腔出血后低钠血症合并发生率为37.0%(95%CI 31.7%-42.4%)。
- 低钠血症增加血管痉挛风险(OR 2.93,95%CI 1.77-4.84)并延长住院时间(16.4天 vs 8.0天,均差8.5天,95%CI 4.6-12.4)。
- 低钠血症与不良结局(GOS≤3)无显著关联(OR 1.15,95%CI 0.44-3.02)。
核心结论
- 低钠血症在动脉瘤性蛛网膜下腔出血后常见,可能增加血管痉挛的可能性,但单独来看似乎不影响总体结局。
- 有效管理低钠血症应是治疗临床医生的优先事项。
研究设计与样本
- 遵循PRISMA的系统评价与Meta分析(国际前瞻性系统评价注册号CRD42022363472)。
- 检索MEDLINE、Embase和Cochrane Library中1990年1月至2024年1月发表的文章。
- 共纳入52项研究,10512例患者。
- 多数研究纳入收治于三级神经科学中心(61.5%,N=32)或重症监护病房(23.1%,N=11)的患者。
主要发现
- 血钠低于135 mmol/L是最常用的低钠血症定义(84.6%,N=44)。
- 低钠血症合并发生率为37.0%(95%CI 31.7%-42.4%)。
- 低钠血症增加血管痉挛风险(15项研究;OR 2.93;95%CI 1.77-4.84)。
- 低钠血症延长住院时间(3项研究,16.4天 vs 8.0天,均差8.5天[95%CI 4.6-12.4])。
- 低钠血症与不良结局(GOS≤3)无显著关联(10项研究;OR 1.15;95%CI 0.44-3.02)。
关键数值与推荐
- 低钠血症定义为血钠低于135 mmol/L(84.6%,N=44项研究采用)。
- 不良结局定义为格拉斯哥结局量表评分3分或以下(GOS≤3)。
- 对不同的低钠血症和结局定义、偏倚及aSAH人群进行敏感性分析后,上述发现保持不变。
临床怎么用
- 原文结论指出有效管理低钠血症应是治疗临床医生的优先事项。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hyponatremia after aneurysmal subarachnoid hemorrhage (aSAH) is common; however, the incidence, and association with vasospasm, morbidity, and mortality, has yet to be defined. We aimed to identify incidence of hyponatremia after aSAH, and quantify its association with measurable outcomes. METHODS: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant systematic review and meta-analysis was conducted (international prospective register of systematic reviews ID CRD42022363472). Articles published in MEDLINE, Embase, and Cochrane Library between January 1990 and January 2024 were included. Hyponatremia definitions, incidence during admission, and association among vasospasm, length of hospital stay, and poor outcome (Glasgow Outcome Scale 3 or less) were identified. Pooled incidence rates and binary and continuous outcomes were calculated using random effects meta-analysis models. RESULTS: In total, 52 studies (10,512 patients) were included. Most studies included patients admitted to tertiary neuroscience centers (61.5%, N = 32), or critical care units (23.1%, N = 11). Sodium of less than 135 mmol/L was the most commonly used hyponatremia definition (84.6%, N = 44). The pooled incidence of hyponatremia was 37.0% (95% confidence interval [CI]: 31.7%-42.4%). Hyponatremia increased the risk of vasospasm (15 studies; odds ratio: 2.93; 95% CI: 1.77-4.84), and length of hospital stay (3 studies, 16.4 days vs. 8.0 days, mean difference 8.5 [95% CI: 4.6-12.4]), but was not associated with poor outcome (10 studies; odds ratio 1.15; 95% CI 0.44-3.02). These findings remained when carrying out sensitivity analysis for different hyponatremia and outcome definitions, bias, and aSAH populations. CONCLUSIONS: Hyponatremia is common in aSAH, may increase the likelihood of vasospasm, but in isolation does not appear to affect overall outcomes. Managing hyponatremia effectively should be a priority for treating clinicians.
引用
- Gillespie CS, Mihaela-Vasilica A, Dhaliwal J, et al. Hyponatremia Incidence After Subarachnoid Hemorrhage and Association with Outcomes: Systematic Review and Meta-Analysis. World Neurosurg. 2025. PMID: 39732459. doi:10.1016/j.wneu.2024.123616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。